Copenhagen, 2016-03-16 16:32 CET (GLOBE NEWSWIRE) -- The annual general meeting of Exiqon A/S was held today, 16 March 2016, at the Company’s address, Skelstedet 16, DK-2950 Vedbæk, where the general meeting resolved:
1. To adopt the audited annual report.
2. To appropriate the result of the year as proposed in the audited annual report.
3. To approve the supervisory board’s remuneration for 2016 as proposed by the supervisory board.
4. To re-elect Erik Walldén, Thorleif Krarup, Michael Nobel, Per Wold-Olsen and Rodney Turner as members of the company’s supervisory board.
5. To re-appoint KPMG Statsautoriseret Revisionspartnerselskab as the company’s auditor.
6. The proposal to authorize the chairman of the meeting to file the resolutions was revoked.
At a supervisory board meeting held immediately after the general meeting, the supervisory board elected Erik Walldén as chairman of the supervisory board and Thorleif Krarup as vice chairman of the supervisory board. The composition of the supervisory board is as follows:
Erik Walldén, chairman
Thorleif Krarup, vice chairman
Michael Nobel
Per Wold-Olsen
Rodney Turner
Additional information
Lars Kongsbak, CEO, tel. +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, tel. +45 4566 0888 (cell: +45 4090 2131)
About Exiqon
At Exiqon, we advance the research of when and where genes are expressed. We empower scientists across the world with best-in-class products and user-friendly business solutions designed to transform workflows in our industry. Exiqon operates in two business areas: Exiqon Life Sciences is a leading provider of flexible solutions for gene expression analysis. Academia, biotech and pharmaceutical companies around the world use Exiqon’s research products to make ground-breaking discoveries. Exiqon Diagnostics collaborates with diagnostic and pharmaceutical companies to develop novel molecular diagnostic tests for early detection of diseases, which can help physicians make better treatment decisions. Exiqon is listed on Nasdaq Copenhagen. For more information about us, please visit www.exiqon.com
